Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chongqing Zhifei Biological Products
Pharma
Takeda-Denali, Merck-Zhifei, Shionogi—Fierce Pharma Asia
Takeda ended its partnership with Denali. Merck and Zhifei adjusted their vaccine distribution deal. Shionogi won funding from the U.S. government.
Angus Liu
Apr 10, 2026 8:00am
Merck, Zhifei rework their China vaccine distribution agreement
Apr 7, 2026 11:38am
China's 9-valent HPV vaccine priced at 60% discount to Merck jab
Jul 10, 2025 11:10am
Sanofi, GSK and China reimbursement updates—Fierce Pharma Asia
Dec 6, 2024 9:00am
GSK cuts Shingrix deliveries in revised Zhifei China pact
Dec 5, 2024 10:52am
GSK partners up with Zhifei to market Shingrix in China
Oct 9, 2023 11:20am
